BioCentury
ARTICLE | Company News

NASH play Madrigal gains on takeout report

June 13, 2018 9:34 PM UTC

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) gained $30.53 (11%) to $313.24 Wednesday on takeout rumors.

Madrigal Chairman and CEO Paul Friedman told BioCentury the company has "an open mind to strategics who would either want to partner or acquire us." He did not give details...

BCIQ Company Profiles

Madrigal Pharmaceuticals Inc.